Costa Franco Luís Salume, Boldrini Neide Aparecida Tosato, Caldeira Caroline Simões, Ferrugini Carolina Loyola Prest, Volpini Lays Paula Bondi, Saldanha Fenísia Gabrielle Carvalho, Soares Lucas Delboni, Miranda Angelica Espinosa
Universidade Federal do Espírito Santo, Programa de Pós-Graduação em Doenças Infecciosas, Vitória, ES, Brazil.
Universidade Federal do Espírito Santo, Departamento de Ginecologia e Obstetrícia, Vitória, ES, Brazil.
Epidemiol Serv Saude. 2024 Dec 16;33(spe1):e2024279. doi: 10.1590/S2237-96222024v33e2024279.especial.en. eCollection 2024.
The aim of this study was to determine the prevalence of HPV and cytological alterations in the transgender population and contribute to the development of public policies.
A descriptive study was conducted in a transgender outpatient clinic in Vitória, Espírito Santo state, between 2018 and 2021. Data were collected through interviews and information from medical records. Anogenital samples were collected for HPV, trichomoniasis, gonococcus and chlamydia testing, cytology.
Of the 110 participants, 60.9% identified as men and 34.5% as women. The overall prevalence of HPV was 58.3%, being higher in women (48.1%). Among men, cervical HPV was positive in 38%, and anal HPV in 25%, with cytological abnormalities found in 9.5%. Abnormal anal cytology was observed in 23.5% of women. Other sexually transmitted infections: chlamydia (4.1%), trichomoniasis (12.5%) and no cases of gonorrhea.
HPV is a prevalent infection with risks for cytological abnormalities in the transgender population, and further studies on prevalence and impacts on sexual health are needed to support screening and prevention policies.
Transgender people are susceptible to sexually transmitted infections, with a high prevalence of HPV and, consequently, present cytological abnormalities in the anal and cervical regions, which pose a risk for the development of anogenital neoplasia.
This is an invisible population, often absent from health services due to prejudice and stigma. Data on the health of this population contributes to the formulation of inclusive policies for the prevention, screening and diagnosis of STIs and anogenital neoplasia .
Increased support are for further studies on STIs and anogenital neoplasia in the transgender population is needed, through investments in specialized outpatient clinics and research groups, so that public policies can be discussed and implemented.
本研究旨在确定跨性别群体中HPV感染率及细胞学改变情况，并为公共政策的制定提供参考。
2018年至2021年期间，在圣埃斯皮里图州维多利亚市的一家跨性别门诊进行了一项描述性研究。通过访谈和病历信息收集数据。采集肛门生殖器样本进行HPV、滴虫、淋病奈瑟菌和衣原体检测及细胞学检查。
110名参与者中，60.9%认定为男性，34.5%认定为女性。HPV总体感染率为58.3%，女性感染率更高（48.1%）。男性中，宫颈HPV阳性率为38%，肛门HPV阳性率为25%，细胞学异常率为9.5%。23.5%的女性存在肛门细胞学异常。其他性传播感染情况：衣原体感染率为4.1%，滴虫感染率为12.5%，未发现淋病病例。
HPV在跨性别群体中是一种常见感染，存在细胞学异常风险，需要进一步研究其感染率及对性健康的影响，以支持筛查和预防政策。
跨性别者易感染性传播感染，HPV感染率高，因此肛门和宫颈区域存在细胞学异常，这增加了肛门生殖器肿瘤发生的风险。
这是一个易被忽视的群体，由于偏见和污名化，他们常常无法获得医疗服务。该群体的健康数据有助于制定关于性传播感染和肛门生殖器肿瘤预防、筛查及诊断的包容性政策。
需要加大对跨性别群体性传播感染和肛门生殖器肿瘤进一步研究的支持力度，通过投资专业门诊和研究小组，以便能够讨论和实施公共政策。
